(19)
(11) EP 3 213 082 A1

(12)

(43) Date of publication:
06.09.2017 Bulletin 2017/36

(21) Application number: 15785109.8

(22) Date of filing: 27.10.2015
(51) International Patent Classification (IPC): 
G01N 33/574(2006.01)
(86) International application number:
PCT/EP2015/074797
(87) International publication number:
WO 2016/066604 (06.05.2016 Gazette 2016/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 27.10.2014 EP 14190513

(71) Applicant: Oncotyrol Center for Personalized Cancer Medicine GmbH
6020 Innsbruck (AT)

(72) Inventors:
  • BÖSCH, Maximilian
    A-6020 Innsbruck (AT)
  • ZEIMET, Alain Gustave
    A-6020 Innsbruck (AT)
  • REIMER, Daniel Uwe
    A-6020 Innsbruck (AT)
  • SOPPER, Sieghart
    A-6020 Innsbruck (AT)
  • WOLF, Dominik
    A-6020 Innsbruck (AT)

(74) Representative: Sonn & Partner Patentanwälte 
Riemergasse 14
1010 Wien
1010 Wien (AT)

   


(54) VAV3 AS A MARKER FOR CANCER